Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 14/12/2019
SIETES contiene 92854 citas

 
 
 1 a 20 de 80 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
2.Enlace a cita original Cita con resumen
Avery AJ, Bell BG. Rationalising medications through deprescribing. BMJ 2019;364:7 de febrero. [Ref.ID 103031]
3.Enlace a cita original Cita con resumen
Hadland SE, Rivera-Aguirre A, Marshall BDL, Cerdá M. Association of pharmaceutical industry marketing of opioid products with mortality from opioid-related overdoses. JAMA Network Open 2019;2:18 de enero. [Ref.ID 103009]
4. Cita con resumen
Habibi R, Lexchin J, Mintzes B, Holbrook A. Unwarranted claims of drug efficacy in pharmaceutical sales visits: are drugs approved on the basis of surrogate outcomes promoted appropriately?. Br J Clin Pharmacol 2017;83:2549-56. [Ref.ID 102116]
8. Cita con resumen
Larkin I, Ang D, Steinhart J, Chao M, Patterson M, Sah S, Wu T, Schoen-baum M, Hutchins D, Brennan T, Loewen-stein G. Association between academic medical center pharmaceutical detailing policies and physician prescribing. JAMA 2017;317:1785-95. [Ref.ID 101559]
9. Cita con resumen
Anónimo. Analysis: drug companies increasingly marketing to hospital administrators. DIA Daily 2014:25 de septiembre. [Ref.ID 97956]
10. Cita con resumen
Avorn J. Healing the overwhelmed physician. N Y Times (Print) 2013:11 de junio. [Ref.ID 95635]
11. Cita con resumen
Garcés Redondo G, Colán Colán C, Sánchez Oropesa A, Gómez Suanes G, Canchig Pilicita FE, López de Castro F. Opinión sobre la visita médica de los médicos de atención primaria de Toledo . Revista Clínica de Medicina de Familia 2010;3:5-9. [Ref.ID 95295]
12. Cita con resumen
Silversides A. Tight rules for French drug reps give doctors better data. BMJ 2010;341:1241. [Ref.ID 89774]
13. Cita con resumen
Sandars J. Continuing medical education across Europe. BMJ 2010;341:680-1. [Ref.ID 89449]
14.Enlace a cita original
Lea D, Spigset O, Slordal L. Norwegian medical students' attitudes towards the pharmaceutical industry. Eur J Clin Pharmacol 2010;66:727-33. [Ref.ID 88816]
15. Cita con resumen
Stafford RS. Regulating off-label drug use - rethinking the role of the FDA. N Engl J Med 2008;358:1427-9. [Ref.ID 82522]
16.Tiene citas relacionadas
Campbell EG. A national survey of physician - industry relationships. The author replies. N Engl J Med 2007;357:508. [Ref.ID 80741]
17.Tiene citas relacionadas
Gorske AL. A national survey of physician - industry relationships. N Engl J Med 2007;357:508. [Ref.ID 80740]
18.Tiene citas relacionadas
Grande D. A national survey of physician - industry relationships. N Engl J Med 2007;357:507-8. [Ref.ID 80739]
19.Tiene citas relacionadas
Sade RM. A national survey of physician - industry relationships. N Engl J Med 2007;357:507. [Ref.ID 80738]
20.Tiene citas relacionadas Cita con resumen
Campbell EG, Gruen RL, Mountford J, Miller LG, Cleary PD, Blumenthal D. A national survey of physician - Industry relationships. N Engl J Med 2007;356:1742-50. [Ref.ID 79881]
Seleccionar todas
 
 1 a 20 de 80 siguiente >>